| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Department of Internal Medicine I, University of Ulm, 89081 Ulm, Germany
The aim of this study was to examine the effects of transforming growth factor (TGF) ß1 on the phenotype and the biological behavior of pancreatic cancer cell lines with and without mutations in the TGF-ß signaling pathway and to elucidate whether the Ras signaling cascade participates in mediating these effects of TGF-ß1. TGF-ß-responsive (PANC-1, COLO-357, and IMIM-PC1) and nonresponsive (CAPAN1 and IMIM-PC2) pancreatic cancer cell lines with activating mutations of the Ki-Ras oncogene were treated with 10 ng/ml TGF-ß1 over time. Phenotypic alterations were studied by electron and phase contrast microscopy and by immunohistochemistry and expression analyses of differentiation markers. The influence of TGF-ß on tumor cell scattering, migration, and invasion was determined. The role of the Ras-mitogen-activated protein kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) cascade in mediating TGF-ß-induced morphological and functional effects were studied by pretreatment with the MEK1 inhibitor PD 98059 and by measuring ERK2 activation using immune complex kinase assays. TGF-ß1 led to a reversible and time-dependent epithelial-mesenchymal transdifferentiation (EMT) in TGF-ß-responsive pancreatic cancer cell lines, characterized by a fibroblastoid morphology and an up-regulation of mesenchymal markers and a down-regulation of epithelial markers. EMT was associated with an increase in tumor cell migration, invasion, and scattering. In the responsive cell lines, TGF-ß1 induced a moderate but sustained activation of ERK2. EMT, the concomitant changes in gene expression, and the invasive and migratory potential were reduced or abolished by pretreatment with the selective MEK1 inhibitor. Thus, in TGF-ß-responsive pancreatic cancer cells with activating Ki-Ras mutations, TGF-ß1 treatment caused an EMT associated with a more invasive phenotype. Cross-talk with the Ras-MEK-ERK-signaling cascade appears to be essential for mediating these effects of TGF-ß1.
This article has been cited by other articles:
![]() |
T.-L. Hackett, S. M. Warner, D. Stefanowicz, F. Shaheen, D. V. Pechkovsky, L. A. Murray, R. Argentieri, A. Kicic, S. M. Stick, T. R. Bai, et al. Induction of Epithelial-Mesenchymal Transition in Primary Airway Epithelial Cells from Patients with Asthma by Transforming Growth Factor-{beta}1 Am. J. Respir. Crit. Care Med., July 15, 2009; 180(2): 122 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Geismann, M. Morscheck, D. Koch, F. Bergmann, H. Ungefroren, A. Arlt, M.-S. Tsao, M. G. Bachem, P. Altevogt, B. Sipos, et al. Up-regulation of L1CAM in Pancreatic Duct Cells Is Transforming Growth Factor {beta}1- and Slug-Dependent: Role in Malignant Transformation of Pancreatic Cancer Cancer Res., May 15, 2009; 69(10): 4517 - 4526. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Gordon, K. C. Kirkbride, T. How, and G. C. Blobe Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2 Carcinogenesis, February 1, 2009; 30(2): 238 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Gordon, M. Dong, E. M. Chislock, T. A. Fields, and G. C. Blobe Loss of type III transforming growth factor {beta} receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression Carcinogenesis, February 1, 2008; 29(2): 252 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Javle, J. F. Gibbs, K. K. Iwata, Y. Pak, P. Rutledge, J. Yu, J. D. Black, D. Tan, and T. Khoury Epithelial-Mesenchymal Transition (EMT) and Activated Extracellular Signal-regulated Kinase (p-Erk) in Surgically Resected Pancreatic Cancer Ann. Surg. Oncol., December 1, 2007; 14(12): 3527 - 3533. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Gaspar, L. Li, A. M. Kapoun, S. Medicherla, M. Reddy, G. Li, G. O'Young, D. Quon, M. Henson, D. L. Damm, et al. Inhibition of Transforming Growth Factor beta Signaling Reduces Pancreatic Adenocarcinoma Growth and Invasiveness Mol. Pharmacol., July 1, 2007; 72(1): 152 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Choi, S. Y. Park, and C.-K. Joo Transforming Growth Factor-{beta}1 Represses E-Cadherin Production via Slug Expression in Lens Epithelial Cells Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2708 - 2718. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Ripka, A Konig, M Buchholz, M Wagner, B Sipos, G Kloppel, J Downward, T. Gress, and P Michl WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer Carcinogenesis, June 1, 2007; 28(6): 1178 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gu, L. F. Zerbini, H. H. Otu, M. Bhasin, Q. Yang, M. G. Joseph, F. Grall, T. Onatunde, R. G. Correa, and T. A. Libermann Reduced PDEF Expression Increases Invasion and Expression of Mesenchymal Genes in Prostate Cancer Cells Cancer Res., May 1, 2007; 67(9): 4219 - 4226. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki, M. C. Wilkes, N. Garamszegi, M. Edens, and E. B. Leof Transforming Growth Factor {beta} Signaling via Ras in Mesenchymal Cells Requires p21-Activated Kinase 2 for Extracellular Signal-Regulated Kinase-Dependent Transcriptional Responses Cancer Res., April 15, 2007; 67(8): 3673 - 3682. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhang, K. A. Kernan, S. J. Collins, X. Cai, J. M. Lopez-Guisa, J. L. Degen, Y. Shvil, and A. A. Eddy Plasmin(ogen) Promotes Renal Interstitial Fibrosis by Promoting Epithelial-to-Mesenchymal Transition: Role of Plasmin-Activated Signals J. Am. Soc. Nephrol., March 1, 2007; 18(3): 846 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takano, F. Kanai, A. Jazag, H. Ijichi, J. Yao, H. Ogawa, N. Enomoto, M. Omata, and A. Nakao Smad4 is Essential for Down-regulation of E-cadherin Induced by TGF-{beta} in Pancreatic Cancer Cell Line PANC-1 J. Biochem., March 1, 2007; 141(3): 345 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jungert, A. Buck, M. Buchholz, M. Wagner, G. Adler, T. M. Gress, and V. Ellenrieder Smad-Sp1 complexes mediate TGF{beta}-induced early transcription of oncogenic Smad7 in pancreatic cancer cells Carcinogenesis, December 1, 2006; 27(12): 2392 - 2401. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bardeesy, K.-h. Cheng, J. H. Berger, G. C. Chu, J. Pahler, P. Olson, A. F. Hezel, J. Horner, G. Y. Lauwers, D. Hanahan, et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes & Dev., November 15, 2006; 20(22): 3130 - 3146. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ao, K. Williams, N. A. Bhowmick, and S. W. Hayward Transforming Growth Factor-{beta} Promotes Invasion in Tumorigenic but not in Nontumorigenic Human Prostatic Epithelial Cells Cancer Res., August 15, 2006; 66(16): 8007 - 8016. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Hezel, A. C. Kimmelman, B. Z. Stanger, N. Bardeesy, and R. A. DePinho Genetics and biology of pancreatic ductal adenocarcinoma. Genes & Dev., May 15, 2006; 20(10): 1218 - 1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Lacher, M. I. Tiirikainen, E. F. Saunier, C. Christian, M. Anders, M. Oft, A. Balmain, R. J. Akhurst, and W. M. Korn Transforming Growth Factor-{beta} Receptor Inhibition Enhances Adenoviral Infectability of Carcinoma Cells via Up-Regulation of Coxsackie and Adenovirus Receptor in Conjunction with Reversal of Epithelial-Mesenchymal Transition Cancer Res., February 1, 2006; 66(3): 1648 - 1657. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Yang, E. R. Camp, F. Fan, L. Shen, M. J. Gray, W. Liu, R. Somcio, T. W. Bauer, Y. Wu, D. J. Hicklin, et al. Vascular Endothelial Growth Factor Receptor-1 Activation Mediates Epithelial to Mesenchymal Transition in Human Pancreatic Carcinoma Cells Cancer Res., January 1, 2006; 66(1): 46 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vogelmann, M.-D. Nguyen-tat, K. Giehl, G. Adler, D. Wedlich, and A. Menke TGF{beta}-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN J. Cell Sci., October 15, 2005; 118(20): 4901 - 4912. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Groth, M. Schulze, H. Kalthoff, F. Fandrich, and H. Ungefroren Adhesion and Rac1-dependent Regulation of Biglycan Gene Expression by Transforming Growth Factor-{beta}: EVIDENCE FOR OXIDATIVE SIGNALING THROUGH NADPH OXIDASE J. Biol. Chem., September 30, 2005; 280(39): 33190 - 33199. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Levy and C. S. Hill Smad4 Dependency Defines Two Classes of Transforming Growth Factor {beta} (TGF-{beta}) Target Genes and Distinguishes TGF-{beta}-Induced Epithelial-Mesenchymal Transition from Its Antiproliferative and Migratory Responses Mol. Cell. Biol., September 15, 2005; 25(18): 8108 - 8125. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, E. Galardi, M. Duquette, J. Lawler, and S. Parangi Antiangiogenic Treatment with Three Thrombospondin-1 Type 1 Repeats versus Gemcitabine in an Orthotopic Human Pancreatic Cancer Model Clin. Cancer Res., August 1, 2005; 11(15): 5622 - 5630. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Boyer Arnold and M. Korc Smad7 Abrogates Transforming Growth Factor-{beta}1-mediated Growth Inhibition in COLO-357 Cells through Functional Inactivation of the Retinoblastoma Protein J. Biol. Chem., June 10, 2005; 280(23): 21858 - 21866. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N.M. Fischer, B. Herrera, M. Mikula, V. Proell, E. Fuchs, J. Gotzmann, R. Schulte-Hermann, H. Beug, and W. Mikulits Integration of Ras subeffector signaling in TGF-{beta} mediated late stage hepatocarcinogenesis Carcinogenesis, May 1, 2005; 26(5): 931 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Y. Rhyu, Y. Yang, H. Ha, G. T. Lee, J. S. Song, S.-t. Uh, and H. B. Lee Role of Reactive Oxygen Species in TGF-{beta}1-Induced Mitogen-Activated Protein Kinase Activation and Epithelial-Mesenchymal Transition in Renal Tubular Epithelial Cells J. Am. Soc. Nephrol., March 1, 2005; 16(3): 667 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ungefroren, S. Groth, M. Ruhnke, H. Kalthoff, and F. Fandrich Transforming Growth Factor-{beta} (TGF-{beta}) Type I Receptor/ALK5-dependent Activation of the GADD45{beta} Gene Mediates the Induction of Biglycan Expression by TGF-{beta} J. Biol. Chem., January 28, 2005; 280(4): 2644 - 2652. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.S. Prime, M. Davies, M. Pring, and I.C. Paterson THE ROLE OF TGF-{beta} IN EPITHELIAL MALIGNANCY AND ITS RELEVANCE TO THE PATHOGENESIS OF ORAL CANCER (PART II) Critical Reviews in Oral Biology & Medicine, November 1, 2004; 15(6): 337 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Subramanian, R. E. Schwarz, L. Higgins, G. McEnroe, S. Chakravarty, S. Dugar, and M. Reiss Targeting Endogenous Transforming Growth Factor {beta} Receptor Signaling in SMAD4-Deficient Human Pancreatic Carcinoma Cells Inhibits Their Invasive Phenotype1 Cancer Res., August 1, 2004; 64(15): 5200 - 5211. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tian, S. D. Byfield, W. T. Parks, C. H. Stuelten, D. Nemani, Y. E. Zhang, and A. B. Roberts Smad-Binding Defective Mutant of Transforming Growth Factor {beta} Type I Receptor Enhances Tumorigenesis but Suppresses Metastasis of Breast Cancer Cell Lines Cancer Res., July 1, 2004; 64(13): 4523 - 4530. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Li, W. Wang, X. R. Huang, M. Oldfield, A. M. Schmidt, M. E. Cooper, and H. Y. Lan Advanced Glycation End Products Induce Tubular Epithelial-Myofibroblast Transition through the RAGE-ERK1/2 MAP Kinase Signaling Pathway Am. J. Pathol., April 1, 2004; 164(4): 1389 - 1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kloeker, M. B. Major, D. A. Calderwood, M. H. Ginsberg, D. A. Jones, and M. C. Beckerle The Kindler Syndrome Protein Is Regulated by Transforming Growth Factor-{beta} and Involved in Integrin-mediated Adhesion J. Biol. Chem., February 20, 2004; 279(8): 6824 - 6833. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Seton-Rogers, Y. Lu, L. M. Hines, M. Koundinya, J. LaBaer, S. K. Muthuswamy, and J. S. Brugge Cooperation of the ErbB2 receptor and transforming growth factor {beta} in induction of migration and invasion in mammary epithelial cells PNAS, February 3, 2004; 101(5): 1257 - 1262. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Short, R. A. Nemenoff, W. M. Zawada, K. R. Stenmark, and M. Das Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts Am J Physiol Cell Physiol, February 1, 2004; 286(2): C416 - C425. [Abstract] [Full Text] |
||||
![]() |
J. Shao, B. M. Evers, and H. Sheng Roles of Phosphatidylinositol 3'-Kinase and Mammalian Target of Rapamycin/p70 Ribosomal Protein S6 Kinase in K-Ras-Mediated Transformation of Intestinal Epithelial Cells Cancer Res., January 1, 2004; 64(1): 229 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, W. Qiao, L. Chen, X. Xu, X. Yang, D. Li, C. Li, S. G. Brodie, M. M. Meguid, L. Hennighausen, et al. Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice Development, December 15, 2003; 130(24): 6143 - 6153. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Michl, C. Barth, M. Buchholz, M. M. Lerch, M. Rolke, K.-H. Holzmann, A. Menke, H. Fensterer, K. Giehl, M. Lohr, et al. Claudin-4 Expression Decreases Invasiveness and Metastatic Potential of Pancreatic Cancer Cancer Res., October 1, 2003; 63(19): 6265 - 6271. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Rey, J. Yuan, S. H. Young, and E. Rozengurt Protein Kinase C{nu}/Protein Kinase D3 Nuclear Localization, Catalytic Activation, and Intracellular Redistribution in Response to G Protein-coupled Receptor Agonists J. Biol. Chem., June 20, 2003; 278(26): 23773 - 23785. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guha, J. A. Lunn, C. Santiskulvong, and E. Rozengurt Neurotensin Stimulates Protein Kinase C-dependent Mitogenic Signaling in Human Pancreatic Carcinoma Cell Line PANC-1 Cancer Res., May 15, 2003; 63(10): 2379 - 2387. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Bates and A. M. Mercurio Tumor Necrosis Factor-{alpha} Stimulates the Epithelial-to-Mesenchymal Transition of Human Colonic Organoids Mol. Biol. Cell, May 1, 2003; 14(5): 1790 - 1800. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mareel and A. Leroy Clinical, Cellular, and Molecular Aspects of Cancer Invasion Physiol Rev, April 1, 2003; 83(2): 337 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Iacobuzio-Donahue, A. Maitra, M. Olsen, A. W. Lowe, N. T. Van Heek, C. Rosty, K. Walter, N. Sato, A. Parker, R. Ashfaq, et al. Exploration of Global Gene Expression Patterns in Pancreatic Adenocarcinoma Using cDNA Microarrays Am. J. Pathol., April 1, 2003; 162(4): 1151 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ungefroren, W. Lenschow, W.-B. Chen, F. Faendrich, and H. Kalthoff Regulation of Biglycan Gene Expression by Transforming Growth Factor-beta Requires MKK6-p38 Mitogen-activated Protein Kinase Signaling Downstream of Smad Signaling J. Biol. Chem., March 21, 2003; 278(13): 11041 - 11049. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Howe, J. Gauldie, and D. M. McKay TGF-beta effects on epithelial ion transport and barrier: reduced Cl- secretion blocked by a p38 MAPK inhibitor Am J Physiol Cell Physiol, December 1, 2002; 283(6): C1667 - C1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Grande, A. Franzen, J.-O. Karlsson, L. E. Ericson, N.-E. Heldin, and M. Nilsson Transforming growth factor-{beta} and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes J. Cell Sci., November 15, 2002; 115(22): 4227 - 4236. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Valdes, A. M. Alvarez, A. Locascio, S. Vega, B. Herrera, M. Fernandez, M. Benito, M. A. Nieto, and I. Fabregat The Epithelial Mesenchymal Transition Confers Resistance to the Apoptotic Effects of Transforming Growth Factor {beta} in Fetal Rat Hepatocytes Mol. Cancer Res., November 1, 2002; 1(1): 68 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guha, O. Rey, and E. Rozengurt Neurotensin Induces Protein Kinase C-dependent Protein Kinase D Activation and DNA Synthesis in Human Pancreatic Carcinoma Cell Line PANC-1 Cancer Res., March 1, 2002; 62(6): 1632 - 1640. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |